FlexMedical Solutions

It’s nearly time for Medica 2024! As many of you will be aware, this expo is the largest tradeshow for the Medical, Healthcare and Diagnostics industries in Europe, with over 5,300 exhibitors from almost 70 countries and presents a fantastic opportunity for anyone in the global healthcare market. FlexMedical Solutions are very happy to be once again exhibiting. We offer a unique range of services that are designed to help you, our client, bring your investment to life. We are a globally renowned partner that provides support from concept to commercialisation for the development of Point of Care diagnostics and wearables. This year, Christopher McMurran and Darren L. will be representing us at our booth (Hall 13 / C59) Wearable Technologies AG pavillion, so come along from 11 to 14 November and say hello and see what FMS can do for you. #MEDICA2024 #IVD #wearables #PoC #biosensors #diagnostics #ISO13485 #FlexMedical

#FlexMedical #PointofCare #microfluidics #ISO13485 #Biosensors #Canada

FlexMedical Solutions is excited to announce our participation at MEDICA - Leading International Trade Fair 2024 in Düsseldorf, Germany from November 11-14, 2024! Exhibiting on the Wearable Technologies AG stand, we will be displaying concepts for wearable devices featuring our high-quality biosensors. If you're attending, be sure to visit us in Hall 13 / C59 and explore how our advanced capabilities can support your business and accelerate your product development. Looking forward to seeing you there! #MEDICA2024 #Innovation #IVD #PoC #biosensors #Diagnostics #FlexMedical

Prolight conducts business review at FlexMedical Solutions In September, Prolight conducted a business review at its contract manufacturing partner for the cartridge, FlexMedical Solutions (FMS) in Livingston, UK. The review included a progress update and an inspection of the pilot cartridge manufacturing line and associated support facilities. “It was exciting to see the significant progress FMS has made over the last few months. With building works now complete, it was great to see the first wave of production equipment being installed” said COO Karl Bullen “We are very proud of our facilities and our team and as such it is always a privilege to host our clients. The dedicated Prolight production suite is really taking shape and we are excited to take receipt of the remaining manufacturing equipment in the coming months” said Murray Whyte, CTO. The pilot line at FMS is being commissioned to support the regulatory approvals including the clinical performance study and volumes for commercial launch. With the ability to produce hundreds of thousands of cartridges at a competitive cost of goods, the technologies and processes being developed by FMS are designed to be scalable with future high levels of automation, thus enabling a swift transition to full-scale commercial production.

In our ongoing series discussing how we support customers from concept to commercialisation, today we’re highlighting Phase 2: Development. At this critical stage, we make sure your biosensor design adapts efficiently to new data, prioritising long-term reliability. Our proactive approach means we address challenges effectively, and we ensure your product's performance stays aligned with your vision. This gives you the confidence needed as you move toward validation. For more information, contact us via email at: info@flexmedical-solutions.com #Biosensors #Development #IVD #PoC #Diagnostics #FlexMedical 

In a recent interview with the Go Radio Business Show, our CEO, Kevin Fallon, emphasised our commitment to customer success. Kevin discussed FlexMedical Solutions’ ability to help customers bring their products to market faster and at a lower cost by using our advanced manufacturing capabilities, experience, and efficient operations. Hear directly from our CEO by tuning in from minute 41 of this podcast to learn more about FlexMedical Solutions' vision, mission, and how we support our customers. 🎧Listen here: https://lnkd.in/e7NhQX3Z #IVD #PoC #Diagnostics #Biosensors #Podcast #Leadership #FlexMedical

In a recent interview with the Go Radio Business Show, our CEO, Kevin Fallon, emphasised our commitment to customer success. Kevin discussed FlexMedical Solutions’ ability to help customers bring their products to market faster and at a lower cost by using our advanced manufacturing capabilities, experience, and efficient operations. Hear directly from our CEO by tuning in from minute 41 of this podcast to learn more about FlexMedical Solutions' vision, mission, and how we support our customers. 🎧Listen here: https://lnkd.in/e7NhQX3Z #IVD #PoC #Diagnostics #Biosensors #Podcast #Leadership #FlexMedical

A strong foundation is essential to every successful product development journey. That's why Phase 1 (Feasibility) focuses on ensuring our approach aligns perfectly with your specific needs. From rapid prototyping to rigorous performance assessments, we make sure your concept is not only feasible but also ready for the next steps in development. With our expertise, you can confidently move forward knowing that your product meets the highest standards for manufacturability and stability. Read below for more details on how we can help you during Phase 1 of your product development process. For more information, contact us via email at: info@flexmedical-solutions.com #Diagnostics #IVD #PoC #Biosensors #Innovation #FlexMedical

We are proud to announce that FlexMedical Solutions has been selected as a regional finalist for the prestigious The Spectator Economic Innovator of the Year Awards! Being shortlisted at this level is a huge honour, and we couldn't be prouder of our incredible team who made this possible. If we are successful at the regional level, we’ll be heading to the grand final on 7th November 2024. 🏆 For more information: https://lnkd.in/ehXic7vV #Innovation #Awards #SpectatorEconomicInnovator #IVD #PoC #Diagnostics #Biosensors #FlexMedical 

As part of our ongoing series celebrating the important contributions of our team members here at FlexMedical Solutions, today we would like to spotlight our Assay Development Scientist, Dr. Paul Hush. For the past two years, Paul has been an integral part of our science team. His role involves - and extends beyond - designing, optimising, and testing assays, all of which are crucial for the success of our projects. 🗣️Paul says, “I thrive at FMS because it values innovation and collaboration, creating an environment where every idea is heard and every team member makes a difference.” A heartfelt thank you to Paul for his commitment and dedication!  #employeeappreciation #IVD #PoC #Biosensors #Diagnostics #Flexmedical